Duke University School of Medicine
Charles D. Scales, Jr., MD MSHS is Associate Professor of Urology and Population Health Science, and Associate Dean for Clinical Research Initiatives at Duke University School of Medicine. He completed medical school and residency training in urology at Duke University Medical Center. After residency, Dr. Scales completed the Robert Wood Johnson Foundation Clinical Scholars Program at UCLA, where he received advanced training in health services research, health policy, and quality of care.
Dr. Scales has a strong interest in education, having previously served on the ACGME Review Committee for Urology and as a member of the ACGME Board of Directors. He currently leads a course in quality improvement and data analytics in the Masters of Management in Clinical Informatics program at the Duke University School of Medicine.
From the research perspective, Dr. Scales has a longstanding interest in the epidemiology of and patient care for urinary stone disease. Recent studies have redefined the burden of urinary stone disease in the United States, compared the effectiveness of dominant stone removal technologies, and identified new opportunities for improving patient-centered and policy-relevant outcomes, such as unplanned care after procedural interventions. His research and perspective on urinary stone disease has been highlighted in U.S. News & World Report, Reuters, NPR, and the Wall Street Journal, among other media outlets.
As a result of these investigations, he has an appointment at the Duke Clinical Research Institute where he leads a diverse health services and clinical research program. He has received research support from the National Institute of Aging, the American Geriatrics Society, and philanthropic funding, among other sources. Currently, Dr. Scales is the Principal Investigator for the Scientific Data and Research Center for the NIDDK Urinary Stone Disease Research Network (www.usdrn.org) (U01), which is conducting the Prevention of Urinary Stones with Hydration (PUSH) trial.
Disclosure information not submitted.
Saturday, April 29, 2023
3:05 PM – 3:25 PM CST
Sunday, April 30, 2023
1:00 PM – 3:00 PM CST